Psychotropic medications: a descriptive study of prescription trends in Tabriz, Iran, 2021–2022

Psychotropic medications: a descriptive study of prescription trends in Tabriz, Iran, 2021–2022

Abstract Introduction Mental disorders, such as anxiety and depression, significantly impacted global populations in 2019 and 2020, with COVID-19 causing a surge in prevalence. They affect 13.4% of the people worldwide, and 21% of Iranians have experienced them. Prescription analysis is critical for...

Full description

Bibliographic Details
Main Authors:	Mostafa Farahbakhsh, Ali Fakhari, Ali Azimian, Amin Khameneh, Mahsa Matinkia, Ehsan Aghajani
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	BMC Psychiatry
Subjects:	Psychotropic medications Mental disorders Prescription patterns Gabapentin Psychiatrists
Online Access:	https://doi.org/10.1186/s12888-024-06451-2

Similar Items

Patterns of Psychotropic Medication Prescriptions by Psychiatrists for Private Clinic Outpatients in Kerman Province, Iran
by: Abdolreza Sabahi, et al.
Published: (2014-08-01)

Patterns of Psychotropic Medication Prescriptions by Psychiatrists for Private Clinic Outpatients in Kerman Province, Iran
by: Abdolreza Sabahi, et al.
Published: (2014-08-01)

Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice
by: Antoine Baldacci, et al.
Published: (2023-10-01)

PSYCHOTROPIC MEDICINE PRESCRIPTIONS IN A PRIMARY CARE UNIT IN A BIG CITY OF SÃO PAULO STATE
by: Tatiana Oliveira da Silva, et al.
Published: (2013-03-01)

Psychiatrists’ prescriptions
by: Poduri Gopala Sarma
Published: (2015-01-01)

Association between psychotropic prescriptions and the total amount of psychotropics ingested during an intentional overdose: A single‐center retrospective study
by: Iori Tanahashi, et al.
Published: (2022-06-01)

Impact of psychotropic pro re nata prescription-monitoring programme on prescriptions for inpatients with psychiatric disorders: a retrospective observational study
by: Yoshitaka Saito, et al.
Published: (2025-01-01)

Syndrome-Based Prescription to Optimize Psychotropics: Are CHROME Criteria a Game Changer?
by: Ruben Muñiz, et al.
Published: (2021-04-01)

Trends in Psychotropic Medication Prescriptions in Urban China From 2013 to 2017: National Population-Based Study
by: Lu Xu, et al.
Published: (2021-08-01)

Self-prescription with psychotropic medications by healthcare professionals working at mental health institutions in Saudi Arabia
by: Ibrahim M. Albawardi, et al.
Published: (2024-07-01)

Psychotropic drug prescription patterns and their predictors among older adult patients with schizophrenia in a tertiary-referral psychiatric hospital
by: Mu- Chun Lin, et al.
Published: (2021-01-01)

A Study of Psychotropic Drugs Being Prescribed to the Patients Attending the Psychiatric Outpatient Department in a Tertiary Care Hospital
by: Adit Atul Deshmukh, et al.
Published: (2020-08-01)

First-generation migrants’ use of psychotropic medication in Northern Ireland: a record linkage study
by: Tania Bosqui, et al.
Published: (2019-12-01)

Use of prescription medication prior to suicide in Norway
by: Anne Reneflot, et al.
Published: (2019-04-01)

Appropriateness of psychotropic drug prescriptions in the elderly: structuring tools based on data extracted from the hospital information system to understand physician practices
by: Aurélie Petit-Monéger, et al.
Published: (2019-04-01)

Clinical predictors of psychotropic medication prescription in children with ASD of the ELENA cohort
by: Marie-maude Geoffray, et al.
Published: (2023-07-01)

Glaucoma and Psychotropics
by: T. Cavaco, et al.
Published: (2022-06-01)

Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries
by: Francina Fonseca, et al.
Published: (2021-04-01)

Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study
by: Tony Antoniou, et al.
Published: (2023-01-01)

Psychotropic Medicines for Non-Psychiatric Indications: A Cross-sectional, Observational Study
by: Sonia Shinde Mahajan, et al.
Published: (2022-04-01)

Off-label prescription of psychiatric drugs by non-psychiatrist physicians in three general hospitals in Germany
by: Caroline Lücke, et al.
Published: (2018-02-01)

Concomitant prescription of psychotropic and cardiovascular drugs in elderly patients
by: Zeynep Ozturk, et al.
Published: (2017-10-01)

Practices and attitudes of adult psychiatrists regarding methamphetamine-associated psychotic disorder: an internet based survey conducted in Turkey
by: Mehmet Hamdi Örüm, et al.
Published: (2025-01-01)

Prescribing Privileges for Psychologists: A Public Service or Hazard?
by: Shaheen E. Lakhan
Published: (2007-07-01)

Trends in the utilization of psychotropic medications in China from 2018 to 2021
by: Xinyan Zhang, et al.
Published: (2022-09-01)

Shift work and use of psychotropic medicine: a follow-up study with register linkage
by: Karen Albertsen, et al.
Published: (2020-07-01)

Prescription of psychotropic drugs by non-psychiatrist specialists in Morocco: current practices and educational needs
by: Imane Bensouda Korachi, et al.
Published: (2024-09-01)

Do prescription rates of psychotropic drugs change over three years from nursing home admission?
by: Enrico Callegari, et al.
Published: (2021-09-01)

Jurisprudential study of psychotropic drugs and narcotics
by: Leila Jahanbin
Published: (2021-04-01)

Impact of COVID-19 pandemic on prescription of psychotropic medications in the Italian paediatric population during 2020
by: Francesca Gallinella, et al.
Published: (2024-05-01)

Attitudes and psychotropic preferences of primary care providers in the management of mental disorders: a web-based survey
by: Dilek Örüm
Published: (2024-08-01)

Impact of the COVID-19 Pandemic on the General Mental Health in Sweden: No Observed Changes in the Dispensed Amount of Common Psychotropic Medications in the Region of Scania
by: Mirjam Wolfschlag, et al.
Published: (2021-12-01)

Psychiatrists’ awareness of the cost of medication, rates of social disability pension, and their attitudes regarding knowledge of treatment costs
by: Ido Lurie, et al.
Published: (2022-10-01)

Current Pattern of Psychiatric Comorbidity and Psychotropic Drug Prescription in Child and Adolescent Patients
by: Mengühan Araz Altay, et al.
Published: (2019-05-01)

Pharmacokinetic relationships in psychotropic drugs effects
by: G. B. Kolyvanov, et al.
Published: (2021-06-01)

Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary
by: Julie M. Zito, et al.
Published: (2021-06-01)

Effects of Caregiver Dementia Training in Caregiver–Patient Dyads on Psychotropic Drug Prescription: A Randomized Controlled Study
by: Birkenhäger-Gillesse EG, et al.
Published: (2021-07-01)

Factors Associated with Psychotropic Medications Literacy among Community Pharmacists
by: Abdelrahim Alqudah, et al.
Published: (2023-03-01)

CHARACTERISTICS OF COMSUMPTION OF PSYCHOTROPIC DRUGS AMONG STUDENTS OF HEALTH SCIENCES
by: Gloria I. MARTÍNEZ D., et al.
Published: (2009-02-01)

Psychotropic stewardship: Advancing patient care
by: Haight Robert J. PharmD, BCPP, et al.
Published: (2023-04-01)